Regeneron Pharmaceuticals
REGN
REGN
1,311 hedge funds and large institutions have $66.5B invested in Regeneron Pharmaceuticals in 2024 Q4 according to their latest regulatory filings, with 168 funds opening new positions, 476 increasing their positions, 491 reducing their positions, and 213 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
21% less first-time investments, than exits
New positions opened: 168 | Existing positions closed: 213
32% less capital invested
Capital invested by funds: $97.3B → $66.5B (-$30.8B)
39% less funds holding in top 10
Funds holding in top 10: 23 → 14 (-9)
Holders
1,311
Holding in Top 10
14
Calls
$1.19B
Puts
$1.17B
Top Buyers
| 1 | +$1.17B | |
| 2 | +$680M | |
| 3 | +$409M | |
| 4 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
+$331M |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$243M |
Top Sellers
| 1 | -$1.82B | |
| 2 | -$1.28B | |
| 3 | -$739M | |
| 4 |
Capital Research Global Investors
Los Angeles,
California
|
-$678M |
| 5 |
Massachusetts Financial Services
Boston,
Massachusetts
|
-$419M |